A Complete Assessment Of Markets Products And Players Can Be Found In The World Orthopaedic Market Report 2008.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c78572) has announced the addition of "The World Orthopaedic Market Report 2008" to their offering. Few areas of the medical device industry have such a positive outlook The global orthopaedic market is estimated to have been worth approximately US$29.1 billion in 2006, following growth of 8.8% over the previous year. According to our data, the spinal market became the largest segment during 2006, surpassing the knee implant market for the first time. The fastest growing segments are orthobiologics, spinal and trauma, whilst the more established markets for reconstruction implants and arthroscopy Arthroscopy Definition Arthroscopy is the examination of a joint, specifically, the inside structures. The procedure is performed by inserting a specifically designed illuminated device into the joint through a small incision. equipment are exhibiting more modest growth rates Growth Rates The compounded annualized rate of growth of a company's revenues, earnings, dividends, or other figures. Notes: Remember, historically high growth rates don't always mean a high rate of growth looking into the future. . Growth is being fuelled by a number of factors, including the ageing population, the uptake of orthopaedic surgery at an earlier age, physiological problems due to the increasing incidence of obesity, the development of better and longer-lasting implants and materials, as well as new procedures, in particular, minimally-invasive procedures. Spinal markets continue to forge ahead The spinal implant market experienced approximately 10% growth, excluding currency effects, and was worth around US$5.3 billion in 2006. This segment is one of the fastest-growing markets in orthopaedics, fuelled by the ageing population, treatments for younger patients, the development of better implants, materials and procedures, higher patient demand and the move from fusion technologies to motion-preserving devices. Having grown by 17% in 2005, however, the market slowed in 2006. While there is strong demand for spinal technology, the market environment is difficult, with the clinical requirements of both the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. for product approval and payers for reimbursement leading to the need to invest much time and money in order for products to be accepted. Orthobiologics: increasingly important The global market for orthobiologics was estimated at US$2.3 billion in 2006. This market is projected to almost double by 2010 and reach US$5.3 billion by 2011 at a CAGR CAGR See: Compound Annual Growth Rate of 18.3 per cent. Used increasingly in spinal, total joint, trauma and soft tissue surgeries, synthetic bone graft bone graft Orthopedic surgery Sterilized bony tissue, often of cadaveric origin, used to fill and/or 'sculpt' bone defects Indications Spinal fusion, revision of failed articular prostheses, filling traumatic or malignant bone defects, or periodontal defects. substitutes and resorbables are beginning to replace traditional autografts and allografts allografts (al´  graf´ts),n.pl the transplantation of tissue between genetically nonidentical individuals of the same species. (bone bank grafts) which account for more than 75% of today's bone graft procedures. Bone graft substitutes, processed allograft allograft: see transplantation, medical. products, and genetically engineered genetically engineered adjective Recombinant, see there bone growth factors have significant future potential within orthopaedics. As the global population continues to age and the average level of physical activity grows, the number of orthopaedic procedures which require the use of bone grafts and substitutes will continue to increase. For example, in the spinal market, degenerative disc disease Degeneration of the intervertebral disc, which is often called "degenerative disc disease" (DDD) of the spine, is a common disorder of the lower spine and for some people can cause low back pain and/or leg pain (sciatica). afflicts nearly half the US population between 40 and 60 years of age and approximately 90% of Americans over 60. Contents: Orthopaedic Market World Market Review Growth Drivers 2006/2007 In Review Industry Consolidation Advanced Biomaterial biomaterial /bio·ma·te·ri·al/ (bi?o-mah-ter´e-al) a synthetic dressing with selective barrier properties, used in the treatment of burns; it consists of a liquid solvent (polyethylene glycol-400) and a powdered polymer. Systems Aesculap Alphatec Spine Arthrosurface Artimplant Ascension Orthopedics Biomet Biorthex Corin Depuy Encore Medical Exactech Globus Medical Integra Lifesciences Kyphon Medtronicrecent Key Events Nuvasive Orthofix Regeneration Technologies Small Bone Innovations Smith & Nephew Stryker Symmetry Medical Synthes Tornier Tutogen Medical Wright Medical Group Zimmer Report Methodology & Bibliography Definitions For more information visit http://www.researchandmarkets.com/reports/c78572 Source: Espicom Business Intelligence Introduction Espicom Business Intelligence is a publisher of independent and impartial information and analysis services focusing on the pharmaceutical and medical device markets. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion